| AGIRX | VMGMX | AGIRX / VMGMX | |
| Total Expense Ratio | 1.87 | 0.07 | 2,671% |
| Annual Report Gross Expense Ratio | 1.87 | 0.07 | 2,671% |
| Fund Existence | 23 years | 15 years | - |
| Gain YTD | 8.706 | 9.952 | 87% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 0 | 3000 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 58.5M | 33.8B | 0% |
| Annual Yield % from dividends | 0.00 | 0.62 | - |
| Returns for 1 year | 20.73 | 11.76 | 176% |
| Returns for 3 years | 61.03 | 55.53 | 110% |
| Returns for 5 years | -43.38 | 31.10 | -139% |
| Returns for 10 years | 20.11 | 213.13 | 9% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| TEMUX | 22.59 | N/A | N/A |
| Morgan Stanley Pathway Em Mkts Eq | |||
| MRICX | 26.84 | N/A | N/A |
| MFS Research International C | |||
| ICSSX | 16.85 | N/A | N/A |
| VY® Columbia Small Cp Val & InflectionS | |||
| ALVDX | 11.09 | N/A | N/A |
| American Century Focused Lg Cap Val R6 | |||
| BRUMX | 18.35 | N/A | N/A |
| MFS Blended Research Value Equity R4 | |||